How should Dandy‑Walker malformation of the posterior fossa be evaluated and managed?

Dandy-Walker Malformation: Evaluation and Management

MRI without contrast is the definitive imaging modality for evaluating Dandy-Walker malformation of the posterior fossa, and management centers on treating hydrocephalus when present, with endoscopic third ventriculostomy (ETV) increasingly preferred over shunting in appropriate candidates.

Diagnostic Evaluation

Imaging Approach

MRI is the gold standard for diagnosis 1, 2. The key diagnostic features to identify include:

• Cerebellar vermis hypoplasia or absence
• Cystic dilatation of the fourth ventricle
• Enlarged posterior fossa with elevated tentorium and torcula
• Assessment of aqueductal patency (critical for treatment planning) 3

Contrast is not routinely needed for structural brain malformations presenting with chronic nonprogressive ataxia 1. However, MRI should specifically evaluate:

• Supratentorial ventricular size (quantitative volumetry when possible) 4
• Posterior fossa cyst volume
• Associated CNS malformations (corpus callosum hypoplasia/agenesis, cortical malformations)
• CSF flow dynamics using phase-contrast MRI 5

Prenatal Detection

Ultrasound can identify DWM prenatally, showing large posterior fossa communicating with fourth ventricle, small splayed cerebellar hemispheres, and ventriculomegaly 6. MRI provides superior delineation of vermian hypoplasia and associated anomalies 6.

Genetic Workup

Genetic testing is essential, particularly in classic DWM or vermian hypoplasia variants 7. The recommended sequence:

1. Karyotyping first - detects chromosomal abnormalities in 8.62% of cases, with trisomy-18 most common (2.26%) 7
2. CNV-seq or SNP-array if karyotype normal but clinical suspicion remains
3. Whole-exome sequencing (WES) for cases with normal karyotype and microarray but persistent concern 7

Advanced maternal age increases chromosomal abnormality risk 7.

Management Strategy

Hydrocephalus Treatment Algorithm

Hydrocephalus occurs in up to 80% of DWM patients 4, 5. Treatment decisions should be based on MRI findings of aqueductal patency 3:

For Patients with Patent Aqueduct (Most Common):

Endoscopic third ventriculostomy (ETV) is the preferred initial approach 3, 5:

• Success rate: 66.7% overall 4
• Most failures occur within 4 months 4
• Results in mean 25.2% reduction in supratentorial ventricular volume 4
• Ventricular volume reduction correlates with clinical success 4
• Reduces shunt-dependent complications
• More effective in older children 5

For Patients with Aqueductal Stenosis:

ETV with aqueductal stent placement from third ventricle to posterior fossa cyst 3

Shunting Options When ETV Fails or Contraindicated:

• Ventriculoperitoneal (VP) shunt: More effective for reducing ventricle size 3
• Cystoperitoneal (CP) shunt: More effective for cyst reduction but higher malfunction rate (50% vs 19% for VP) 3
• Single shunting (VP or CP alone) is generally effective for controlling both ventricle and cyst size 5
• Combined VP/CP shunting rarely necessary 3

Monitoring and Follow-up

3-month postoperative MRI with volumetric analysis to assess:

• Supratentorial ventricular volume reduction (primary success indicator) 4
• Posterior fossa cyst size (variable reduction, not essential for good outcome) 4
• Stoma patency if ETV performed 4

Special Considerations

Occipital meningocele with DWM: Novel endoscopic fenestration through the meningocele defect into posterior spinal CSF space can be considered, avoiding shunt placement when infection risk is high 8.

Associated hydrocephalus from intraventricular hemorrhage: May require urgent external ventricular drainage 9.

Prognostic Factors

Outcome depends primarily on 5:

1. Presence and severity of associated CNS malformations
2. Degree of vermian malformation
3. Adequate hydrocephalus control
4. Genetic abnormalities (particularly in classic DWM and vermian hypoplasia) 7

Classic DWM and vermian hypoplasia have significantly worse prognosis than mega cisterna magna variant, with higher rates of pregnancy termination and adverse outcomes 7. Mega cisterna magna generally has favorable outcomes 7.

Common Pitfalls

• Do not rely on CT alone - it misses vermian hypoplasia and associated malformations that MRI clearly delineates 1, 6
• Do not assume cyst reduction is necessary for success - supratentorial ventricular reduction is the key outcome marker 4
• Do not skip genetic testing - 10.27% have detectable genetic abnormalities that impact counseling and prognosis 7
• Assess aqueductal patency before choosing treatment - this determines whether ETV alone is sufficient or stenting is needed 3